Venmax Drugs And Pharmaceuticals
VENMAXBSE

Venmax Drugs And Pharmaceuticals

₹19.320.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
18.21
Today’s high
19.79
52 week low
16.00
52 week high
36.96
Open price
19.35
Previous close
19.32
Live volume
--
Lower circuit
15.46
Upper circuit
23.18

Fundamentals

Market Cap
₹22Cr
ROE
1.76%
P/E Ratio(TTM)
92.19
EPS(TTM)
0.21
P/B Ratio
1.59
Dividend Yield
0.00%
Industry P/E
47.16
Book Value
12.18
Debt to Equity
0.02
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹4.03
+148.77%
Profit (Cr)
₹0.11
+266.67%
01.534.56
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+199%
3Y CAGR-2%
Profit growthValue
1Y (TTM)-86%

About

Venmax is primarily engaged in the manufacturing and trading of pharmaceutical formulations, drug intermediates, and Active Pharmaceutical Ingredients (APIs). The company is currently developing oncology products and is in the planning stages of establishing a new manufacturing unit with a cGMP facility at the Hyderabad Pharma Cluster to target export markets.;
CEO/MD
Mr. Venkata Rao Sadhanala
Founded in
1988
BSE symbol
531015

Shareholding Pattern

Mar '26
Dec '25
Sep '25
Jun '25
Mar '25
Retail And Others
76.72%
Promoters
23.14%
Other Domestic Institutions
0.15%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹889.85
0.00 (--)
L
    H
    22,042.7837.054.33
    PfizerPFIZER
    ₹4,731.40
    0.00 (--)
    L
      H
      21,632.0429.945.15
      ₹8,117.50
      0.00 (--)
      L
        H
        20,309.63108.323.27
        ₹1,431.20
        0.00 (--)
        L
          H
          19,798.7130.575.07
          2026
          14
          May
          Quarterly & Annual Result
          Release date
          7
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks